Gyre Therapeutics Inc. Free Cash Flow Generation Index

Latest as of March 2026: 0.94x

Gyre Therapeutics Inc. free cash flow generation index. Gyre Therapeutics Inc. (GYRE) has a Free Cash Flow Generation Index of 0.94x as of March 2026. Free cash flow of $3.00 Million represents 1% of operating cash flow ($3.18 Million).

FCF Generation Index

0.94x
Free Cash Flow / Operating CF

Free Cash Flow

$3.00 Million
USD

Operating Cash Flow

$3.18 Million
USD

Capital Expenditures

$178.00K
USD

Free Cash Flow Generation Index of Gyre Therapeutics Inc. (2007–2025)

Free cash flow generation index of Gyre Therapeutics Inc. from 2007 to 2025. Historical FCF Generation Index trend for Gyre Therapeutics Inc. across 5 annual periods. See how financially flexible is Gyre Therapeutics Inc. to measure the company's free cash flow as a share of total liabilities.

Gyre Therapeutics Inc. Free Cash Flow Generation Index by Year (2007–2025)

Gyre Therapeutics Inc. free cash flow generation index by year from 2007 to 2025. Year-by-year Free Cash Flow Generation Index for Gyre Therapeutics Inc.. For the full cash flow conversion analysis, see how efficiently does Gyre Therapeutics Inc. generate cash.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 -0.18x $-180.00K $1.01 Million $1.19 Million ▼ -126.7%
2023 0.67x $17.31 Million $25.89 Million $8.59 Million ▲ +25.7%
2022 0.53x $5.68 Million $10.68 Million $5.00 Million ▼ -45.5%
2010 0.98x $134.99 Million $138.30 Million $3.31 Million ▲ +21.9%
2007 0.80x $19.89 Million $24.84 Million $4.94 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).